Eintrag weiter verarbeiten
The Development of Ciprofloxacin Resistance in Pseudomonas aeruginosa Involves Multiple Response Stages and Multiple Proteins
Gespeichert in:
| Zeitschriftentitel: | Antimicrobial Agents and Chemotherapy |
|---|---|
| Personen und Körperschaften: | , , , , , , , |
| In: | Antimicrobial Agents and Chemotherapy, 54, 2010, 11, S. 4626-4635 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
American Society for Microbiology
|
| Schlagwörter: |
| author_facet |
Su, Hsun-Cheng Ramkissoon, Kevin Doolittle, Janet Clark, Martha Khatun, Jainab Secrest, Ashley Wolfgang, Matthew C. Giddings, Morgan C. Su, Hsun-Cheng Ramkissoon, Kevin Doolittle, Janet Clark, Martha Khatun, Jainab Secrest, Ashley Wolfgang, Matthew C. Giddings, Morgan C. |
|---|---|
| author |
Su, Hsun-Cheng Ramkissoon, Kevin Doolittle, Janet Clark, Martha Khatun, Jainab Secrest, Ashley Wolfgang, Matthew C. Giddings, Morgan C. |
| spellingShingle |
Su, Hsun-Cheng Ramkissoon, Kevin Doolittle, Janet Clark, Martha Khatun, Jainab Secrest, Ashley Wolfgang, Matthew C. Giddings, Morgan C. Antimicrobial Agents and Chemotherapy The Development of Ciprofloxacin Resistance in Pseudomonas aeruginosa Involves Multiple Response Stages and Multiple Proteins Infectious Diseases Pharmacology (medical) Pharmacology |
| author_sort |
su, hsun-cheng |
| spelling |
Su, Hsun-Cheng Ramkissoon, Kevin Doolittle, Janet Clark, Martha Khatun, Jainab Secrest, Ashley Wolfgang, Matthew C. Giddings, Morgan C. 0066-4804 1098-6596 American Society for Microbiology Infectious Diseases Pharmacology (medical) Pharmacology http://dx.doi.org/10.1128/aac.00762-10 <jats:title>ABSTRACT</jats:title> <jats:p> Microbes have developed resistance to nearly every antibiotic, yet the steps leading to drug resistance remain unclear. Here we report a multistage process by which <jats:italic>Pseudomonas aeruginosa</jats:italic> acquires drug resistance following exposure to ciprofloxacin at levels ranging from 0.5× to 8× the initial MIC. In stage I, susceptible cells are killed <jats:italic>en masse</jats:italic> by the exposure. In stage II, a small, slow to nongrowing population survives antibiotic exposure that does not exhibit significantly increased resistance according to the MIC measure. In stage III, exhibited at 0.5× to 4× the MIC, a growing population emerges to reconstitute the population, and these cells display heritable increases in drug resistance of up to 50 times the original level. We studied the stage III cells by proteomic methods to uncover differences in the regulatory pathways that are involved in this phenotype, revealing upregulation of phosphorylation on two proteins, succinate-semialdehyde dehydrogenase (SSADH) and methylmalonate-semialdehyde dehydrogenase (MMSADH), and also revealing upregulation of a highly conserved protein of unknown function. Transposon disruption in the encoding genes for each of these targets substantially dampened the ability of cells to develop the stage III phenotype. Considering these results in combination with computational models of resistance and genomic sequencing results, we postulate that stage III heritable resistance develops from a combination of both genomic mutations and modulation of one or more preexisting cellular pathways. </jats:p> The Development of Ciprofloxacin Resistance in <i>Pseudomonas aeruginosa</i> Involves Multiple Response Stages and Multiple Proteins Antimicrobial Agents and Chemotherapy |
| doi_str_mv |
10.1128/aac.00762-10 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin Chemie und Pharmazie |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9hYWMuMDA3NjItMTA |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9hYWMuMDA3NjItMTA |
| institution |
DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 |
| imprint |
American Society for Microbiology, 2010 |
| imprint_str_mv |
American Society for Microbiology, 2010 |
| issn |
0066-4804 1098-6596 |
| issn_str_mv |
0066-4804 1098-6596 |
| language |
English |
| mega_collection |
American Society for Microbiology (CrossRef) |
| match_str |
su2010thedevelopmentofciprofloxacinresistanceinpseudomonasaeruginosainvolvesmultipleresponsestagesandmultipleproteins |
| publishDateSort |
2010 |
| publisher |
American Society for Microbiology |
| recordtype |
ai |
| record_format |
ai |
| series |
Antimicrobial Agents and Chemotherapy |
| source_id |
49 |
| title |
The Development of Ciprofloxacin Resistance in Pseudomonas aeruginosa Involves Multiple Response Stages and Multiple Proteins |
| title_unstemmed |
The Development of Ciprofloxacin Resistance in Pseudomonas aeruginosa Involves Multiple Response Stages and Multiple Proteins |
| title_full |
The Development of Ciprofloxacin Resistance in Pseudomonas aeruginosa Involves Multiple Response Stages and Multiple Proteins |
| title_fullStr |
The Development of Ciprofloxacin Resistance in Pseudomonas aeruginosa Involves Multiple Response Stages and Multiple Proteins |
| title_full_unstemmed |
The Development of Ciprofloxacin Resistance in Pseudomonas aeruginosa Involves Multiple Response Stages and Multiple Proteins |
| title_short |
The Development of Ciprofloxacin Resistance in Pseudomonas aeruginosa Involves Multiple Response Stages and Multiple Proteins |
| title_sort |
the development of ciprofloxacin resistance in
<i>pseudomonas aeruginosa</i>
involves multiple response stages and multiple proteins |
| topic |
Infectious Diseases Pharmacology (medical) Pharmacology |
| url |
http://dx.doi.org/10.1128/aac.00762-10 |
| publishDate |
2010 |
| physical |
4626-4635 |
| description |
<jats:title>ABSTRACT</jats:title>
<jats:p>
Microbes have developed resistance to nearly every antibiotic, yet the steps leading to drug resistance remain unclear. Here we report a multistage process by which
<jats:italic>Pseudomonas aeruginosa</jats:italic>
acquires drug resistance following exposure to ciprofloxacin at levels ranging from 0.5× to 8× the initial MIC. In stage I, susceptible cells are killed
<jats:italic>en masse</jats:italic>
by the exposure. In stage II, a small, slow to nongrowing population survives antibiotic exposure that does not exhibit significantly increased resistance according to the MIC measure. In stage III, exhibited at 0.5× to 4× the MIC, a growing population emerges to reconstitute the population, and these cells display heritable increases in drug resistance of up to 50 times the original level. We studied the stage III cells by proteomic methods to uncover differences in the regulatory pathways that are involved in this phenotype, revealing upregulation of phosphorylation on two proteins, succinate-semialdehyde dehydrogenase (SSADH) and methylmalonate-semialdehyde dehydrogenase (MMSADH), and also revealing upregulation of a highly conserved protein of unknown function. Transposon disruption in the encoding genes for each of these targets substantially dampened the ability of cells to develop the stage III phenotype. Considering these results in combination with computational models of resistance and genomic sequencing results, we postulate that stage III heritable resistance develops from a combination of both genomic mutations and modulation of one or more preexisting cellular pathways.
</jats:p> |
| container_issue |
11 |
| container_start_page |
4626 |
| container_title |
Antimicrobial Agents and Chemotherapy |
| container_volume |
54 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792347377112186881 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T17:53:31.159Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=The+Development+of+Ciprofloxacin+Resistance+in++++++++++++Pseudomonas+aeruginosa++++++++++++Involves+Multiple+Response+Stages+and+Multiple+Proteins&rft.date=2010-11-01&genre=article&issn=1098-6596&volume=54&issue=11&spage=4626&epage=4635&pages=4626-4635&jtitle=Antimicrobial+Agents+and+Chemotherapy&atitle=The+Development+of+Ciprofloxacin+Resistance+in%0A++++++++++++%3Ci%3EPseudomonas+aeruginosa%3C%2Fi%3E%0A++++++++++++Involves+Multiple+Response+Stages+and+Multiple+Proteins&aulast=Giddings&aufirst=Morgan+C.&rft_id=info%3Adoi%2F10.1128%2Faac.00762-10&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792347377112186881 |
| author | Su, Hsun-Cheng, Ramkissoon, Kevin, Doolittle, Janet, Clark, Martha, Khatun, Jainab, Secrest, Ashley, Wolfgang, Matthew C., Giddings, Morgan C. |
| author_facet | Su, Hsun-Cheng, Ramkissoon, Kevin, Doolittle, Janet, Clark, Martha, Khatun, Jainab, Secrest, Ashley, Wolfgang, Matthew C., Giddings, Morgan C., Su, Hsun-Cheng, Ramkissoon, Kevin, Doolittle, Janet, Clark, Martha, Khatun, Jainab, Secrest, Ashley, Wolfgang, Matthew C., Giddings, Morgan C. |
| author_sort | su, hsun-cheng |
| container_issue | 11 |
| container_start_page | 4626 |
| container_title | Antimicrobial Agents and Chemotherapy |
| container_volume | 54 |
| description | <jats:title>ABSTRACT</jats:title> <jats:p> Microbes have developed resistance to nearly every antibiotic, yet the steps leading to drug resistance remain unclear. Here we report a multistage process by which <jats:italic>Pseudomonas aeruginosa</jats:italic> acquires drug resistance following exposure to ciprofloxacin at levels ranging from 0.5× to 8× the initial MIC. In stage I, susceptible cells are killed <jats:italic>en masse</jats:italic> by the exposure. In stage II, a small, slow to nongrowing population survives antibiotic exposure that does not exhibit significantly increased resistance according to the MIC measure. In stage III, exhibited at 0.5× to 4× the MIC, a growing population emerges to reconstitute the population, and these cells display heritable increases in drug resistance of up to 50 times the original level. We studied the stage III cells by proteomic methods to uncover differences in the regulatory pathways that are involved in this phenotype, revealing upregulation of phosphorylation on two proteins, succinate-semialdehyde dehydrogenase (SSADH) and methylmalonate-semialdehyde dehydrogenase (MMSADH), and also revealing upregulation of a highly conserved protein of unknown function. Transposon disruption in the encoding genes for each of these targets substantially dampened the ability of cells to develop the stage III phenotype. Considering these results in combination with computational models of resistance and genomic sequencing results, we postulate that stage III heritable resistance develops from a combination of both genomic mutations and modulation of one or more preexisting cellular pathways. </jats:p> |
| doi_str_mv | 10.1128/aac.00762-10 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin, Chemie und Pharmazie |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9hYWMuMDA3NjItMTA |
| imprint | American Society for Microbiology, 2010 |
| imprint_str_mv | American Society for Microbiology, 2010 |
| institution | DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229 |
| issn | 0066-4804, 1098-6596 |
| issn_str_mv | 0066-4804, 1098-6596 |
| language | English |
| last_indexed | 2024-03-01T17:53:31.159Z |
| match_str | su2010thedevelopmentofciprofloxacinresistanceinpseudomonasaeruginosainvolvesmultipleresponsestagesandmultipleproteins |
| mega_collection | American Society for Microbiology (CrossRef) |
| physical | 4626-4635 |
| publishDate | 2010 |
| publishDateSort | 2010 |
| publisher | American Society for Microbiology |
| record_format | ai |
| recordtype | ai |
| series | Antimicrobial Agents and Chemotherapy |
| source_id | 49 |
| spelling | Su, Hsun-Cheng Ramkissoon, Kevin Doolittle, Janet Clark, Martha Khatun, Jainab Secrest, Ashley Wolfgang, Matthew C. Giddings, Morgan C. 0066-4804 1098-6596 American Society for Microbiology Infectious Diseases Pharmacology (medical) Pharmacology http://dx.doi.org/10.1128/aac.00762-10 <jats:title>ABSTRACT</jats:title> <jats:p> Microbes have developed resistance to nearly every antibiotic, yet the steps leading to drug resistance remain unclear. Here we report a multistage process by which <jats:italic>Pseudomonas aeruginosa</jats:italic> acquires drug resistance following exposure to ciprofloxacin at levels ranging from 0.5× to 8× the initial MIC. In stage I, susceptible cells are killed <jats:italic>en masse</jats:italic> by the exposure. In stage II, a small, slow to nongrowing population survives antibiotic exposure that does not exhibit significantly increased resistance according to the MIC measure. In stage III, exhibited at 0.5× to 4× the MIC, a growing population emerges to reconstitute the population, and these cells display heritable increases in drug resistance of up to 50 times the original level. We studied the stage III cells by proteomic methods to uncover differences in the regulatory pathways that are involved in this phenotype, revealing upregulation of phosphorylation on two proteins, succinate-semialdehyde dehydrogenase (SSADH) and methylmalonate-semialdehyde dehydrogenase (MMSADH), and also revealing upregulation of a highly conserved protein of unknown function. Transposon disruption in the encoding genes for each of these targets substantially dampened the ability of cells to develop the stage III phenotype. Considering these results in combination with computational models of resistance and genomic sequencing results, we postulate that stage III heritable resistance develops from a combination of both genomic mutations and modulation of one or more preexisting cellular pathways. </jats:p> The Development of Ciprofloxacin Resistance in <i>Pseudomonas aeruginosa</i> Involves Multiple Response Stages and Multiple Proteins Antimicrobial Agents and Chemotherapy |
| spellingShingle | Su, Hsun-Cheng, Ramkissoon, Kevin, Doolittle, Janet, Clark, Martha, Khatun, Jainab, Secrest, Ashley, Wolfgang, Matthew C., Giddings, Morgan C., Antimicrobial Agents and Chemotherapy, The Development of Ciprofloxacin Resistance in Pseudomonas aeruginosa Involves Multiple Response Stages and Multiple Proteins, Infectious Diseases, Pharmacology (medical), Pharmacology |
| title | The Development of Ciprofloxacin Resistance in Pseudomonas aeruginosa Involves Multiple Response Stages and Multiple Proteins |
| title_full | The Development of Ciprofloxacin Resistance in Pseudomonas aeruginosa Involves Multiple Response Stages and Multiple Proteins |
| title_fullStr | The Development of Ciprofloxacin Resistance in Pseudomonas aeruginosa Involves Multiple Response Stages and Multiple Proteins |
| title_full_unstemmed | The Development of Ciprofloxacin Resistance in Pseudomonas aeruginosa Involves Multiple Response Stages and Multiple Proteins |
| title_short | The Development of Ciprofloxacin Resistance in Pseudomonas aeruginosa Involves Multiple Response Stages and Multiple Proteins |
| title_sort | the development of ciprofloxacin resistance in <i>pseudomonas aeruginosa</i> involves multiple response stages and multiple proteins |
| title_unstemmed | The Development of Ciprofloxacin Resistance in Pseudomonas aeruginosa Involves Multiple Response Stages and Multiple Proteins |
| topic | Infectious Diseases, Pharmacology (medical), Pharmacology |
| url | http://dx.doi.org/10.1128/aac.00762-10 |